Patriot One’s Xtract AI Division Working With Canexia Health To Increase Access To Cancer Testing VANCOUVER, British Columbia, July 15, 2020 (GLOBE NEWSWIRE) -- Patriot One Technologies Inc.’s (TSX: PAT) (OTCQX: PTOTF) (FRANKFURT: 0PL) wholly-owned subsidiary Xtract Technologies Inc. (“Xtract...

Data Published In AACR Journal Suggest Biodesix® Test in Development May Identify Melanoma Patients Who Could Benefit from Checkpoint Inhibitors BOULDER, Colo., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Findings published in the American Association for Cancer Research (AACR) peer-reviewed journal Cancer Immunology Research demonstrate that a test...

Biodesix Oral Presentation At SITC: Testing Methodology May Identify Primary Immunotherapy Resistance In Patients BOULDER, Colo., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Biodesix® chief technology officer, Dr. Heinrich Roder, will give an oral presentation discussing a proprietary test development methodology that...